Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 300
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05047107 | Biology and Genetics of Smouldering Myeloma | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | ||
| NCT00757991 | Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom | ||
| NCT01431664 | AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia | ||
| NCT05574738 | A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer | ||
| NCT05848765 | Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | ||
| NCT04271371 | Preventing Relapse to Smoking Among Prisoners After Release | ||
| NCT02768337 | Cambridge Brain Mets Trial 1 | ||
| NCT00748527 | Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | ||
| NCT03548688 | Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer: | ||
| NCT01460888 | Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus | ||
| NCT02308527 | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children | ||
| NCT02124369 | Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) | ||
| NCT01566240 | Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer | ||
| NCT02752204 | An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT03590171 | International Study for Treatment of High Risk Childhood Relapsed ALL 2010 | ||
| NCT02695966 | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | ||
| NCT02546921 | Phase I Study of MOv18 IgE | ||
| NCT01505829 | Diffusion-weighted Imaging Study in Cancer of the Ovary | ||
| NCT03527667 | Incentivized Smoking Cessation for Diabetics | ||
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | ||
| NCT03028766 | WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer | ||
| NCT01737255 | Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome | ||
| NCT01413490 | Hepatitis C Rimantadine and Antiviral Combination Therapy | ||
| NCT02540928 | AMG 319 in HPV Positive and Negative HNSCC | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT00958854 | Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma | ||
| NCT03212157 | GlucoCEST MRI in Oncology | ||
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | ||
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT01941849 | Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma | ||
| NCT07172958 | Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) | ||
| NCT07209774 | Healthspan Connect Programme of Research | ||
| NCT05361135 | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia | ||
| NCT00002460 | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | ||
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | ||
| NCT01843829 | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | ||
| NCT00555386 | Soy, Selenium and Breast Cancer Risk | ||
| NCT01266486 | Effect of Metformin on Breast Cancer Metabolism | ||
| NCT06447064 | Cancer Loyalty Card Study 2 (CLOCS-2) | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT01791985 | AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) | ||
| NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | ||
| NCT03529669 | Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer | ||
| NCT02077569 | AKT Inhibitor in Oestrogen Positive Breast Cancer | ||
| NCT03294434 | Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) |
